Semaglutide is also revealed to get prospective kidney benefits in T2D patients driven partially by its hypoglycemic and cardioprotective outcomes [12].Because of its reduction in blood glucose concentrations, semaglutide and various GLP-1-RA’s can often cause hypoglycemic occasions. Having said that, This is certainly unheard of and connected wi